Abstract: The present invention provides pyrrolo[2,3-b]pyridine-4-yl amines pyrrolo[2,3-b]pyrimidin-4-yl amines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.
Type:
Grant
Filed:
October 30, 2007
Date of Patent:
November 8, 2011
Assignee:
Ineyte Corporation
Inventors:
James D. Rodgers, Haisheng Wang, Andrew P. Combs, Richard B. Sparks